Drug Information Association, Washington Marriott Hotel, 1221 22nd Street NW, Washington, DC, USA
Nov 6 2006
The rapid diagnosis of infectious disease has never been more important or relevant. In addition to urgent medical and public health needs posed by emerging infectious diseases (SARS, avian influenza) and bioterrorism, more rapid and accurate
diagnosis of infectious diseases can lead to targeted and more efficient treatments with improved outcomes. The concept of matching a therapeutic entity with diagnostic testing, can ensure the right drug, at the right level, for the right indication,
for the right patient, at the right time.Application of new technology for diagnostic uses offers tremendous potential for changing practice paradigms. New methods in molecular diagnosis, new information
on genomics, proteomics and the biologic basis of infection, along with improvements in portability, robustness, and connectivity have made diagnostic windows possible that would not have even been considered before. Integrating and coordinating multiple facets of today’s healthcare system has been slow and is the fundamental challenge for change. This workshop focuses on approaches to shorten the critical path in new product development and integrating new technology into clinical practice. It will also focus on transitioning new diagnostic tests from the research bench to the laboratory and near-patient settings.
|
|